Physician profile
Yuniet Moya
NPI 1134501067
$464.94
in general payments reported to CMS, 2019-2025
7 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.40 · 2021: $46.37 · 2023: $49.30 · 2024: $150 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $173.13 | 2025 | Watchman Flx |
| Medtronic, INC. | $107.69 | 2024 | Micra |
| Glaxosmithkline, LLC. | $56.09 | 2021-2024 | Arexvy, Shingrix |
| Allergan, INC. | $46.40 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.25 | 2021-2023 | Xarelto |
| Phadia US INC. | $24.57 | 2023 | Immunocap |
| Merck Sharp & Dohme LLC | $15.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuniet Moya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.